Philips secures FDA approval for a new pulse oximeter addressing racial bias with improved accuracy...
Tempus AI agrees to buy Personalis for $1.5 billion to enhance cancer diagnostics and treatment...
Edwards sees boost in heart valve sales driven by increasing demand for TAVR devices and...
Dexcom joins the FDA’s digital health pilot program to accelerate innovative medical technologies with real-world...
US adult obesity rates climbed to 41% between 1999 and 2023. New data reveals severe...
Explore the latest breast cancer treatment developments and the challenges of sequencing antibody-drug conjugates to...
Bispecific antibodies are emerging immunotherapy for relapsed lymphoma and leukemia, offering a viable option when...
Bispecific therapy program by American Oncology Network offers safe outpatient dosing guidelines for community clinics,...
Heart failure management is shifting as pharmacists take on a larger role. Discover how they...
Proton pump inhibitors may reduce the benefit of durvalumab consolidation after chemoradiotherapy for unresectable stage...